Posts by Scotty Chung-Siu

Scotty is a Research Analyst at PharmSource. He holds a BS degree in Biology from George Mason University and an MPH degree from Eastern Virginia Medical School. He’s experienced in data collection, analysis and management, and has done laboratory analysis and safety program development.

Follow the Money to Medical Devices & Diagnostics
Spotlight on Lumicell, Inc.

Lumicell is a private US company that develops technologies that enable surgeons to see cancerous cells left behind before concluding surgical removal of a malignant tumor. It raised $28.7 million in the completion of a venture capital investment as reported in the PharmSource Lead Sheet on December 14, 2017. Corporate Highlights Lumicell was founded in […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Fibrocell Science, Inc.

Fibrocell Science is a US public company that develops personalized autologous cell therapies for aesthetic, medical and scientific applications. It raised $9.3 million in a secondary public offering, as reported in the PharmSource Lead Sheet on December 14, 2017. Corporate Highlights Fibrocell Science was incorporated in Delaware in September 1992. Corporate Headquarters: Exton, PA As […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Tear Film Innovations, Inc.

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Tear Film Innovations is a private US company that develops medical devices for the treatment of evaporative dry eye […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Myovant Sciences, Inc.

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Myovant Sciences Sciences is a US public company that focuses on treatments for women’s health diseases and other endocrine-related disorders. It plans to raise $300 […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Protagonist Therapeutics, Inc.

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Protagonist Therapeutics is a US public company that discovers and develops disulfide-rich peptides, alternatives to antibodies and new chemical entities to treat life-threatening diseases. It […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on AxioMed LLC

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AxioMed is a US private company that focuses on products to address spinal function in patients with degenerative spine […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Cambridge Medical Robotics Ltd.

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Cambridge Medical Robotics is a private company based in the UK that develops next-generation robotic systems for minimal access […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Fusion Pharmaceuticals, Inc.

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Fusion Pharmaceuticals is a private company based in Canada that develops radiotherapeutics for the treatment of cancer. It raised $21 million in a venture capital […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on ARMO BioSciences, Inc.

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. ARMO BioSciences is a US private company that develops immunotherapies for the treatment of cancer, cardiovascular diseases, fibrosis and inflammation. It raised $67 million in […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on SetPoint Medical Corp.

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. SetPoint Medical is a US private company that focuses on implantable neuromodulation devices to treat inflammatory diseases such as […]

Learn more